| Application number | Title of the application | Filing Date | Status |
|---|
| 08/776157 | PROCESS FOR PREPARING VIRUSES AND VIRAL VECTORS | Mar 27, 1997 | Abandoned |
Array
(
[id] => 3808030
[patent_doc_number] => 05831020
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-03
[patent_title] => 'Protein-mediated nuclear import of DNA'
[patent_app_type] => 1
[patent_app_number] => 8/824151
[patent_app_country] => US
[patent_app_date] => 1997-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12014
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/831/05831020.pdf
[firstpage_image] =>[orig_patent_app_number] => 824151
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/824151 | Protein-mediated nuclear import of DNA | Mar 24, 1997 | Issued |
Array
(
[id] => 4040844
[patent_doc_number] => 05874242
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-02-23
[patent_title] => 'Efficient translation in eukaryotic and prokaryotic systems'
[patent_app_type] => 1
[patent_app_number] => 8/821022
[patent_app_country] => US
[patent_app_date] => 1997-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 6736
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/874/05874242.pdf
[firstpage_image] =>[orig_patent_app_number] => 821022
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/821022 | Efficient translation in eukaryotic and prokaryotic systems | Mar 18, 1997 | Issued |
Array
(
[id] => 4022288
[patent_doc_number] => 05882866
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-03-16
[patent_title] => 'Method of isolating ribotopes and proteotopes'
[patent_app_type] => 1
[patent_app_number] => 8/818711
[patent_app_country] => US
[patent_app_date] => 1997-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6015
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/882/05882866.pdf
[firstpage_image] =>[orig_patent_app_number] => 818711
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/818711 | Method of isolating ribotopes and proteotopes | Mar 13, 1997 | Issued |
Array
(
[id] => 4101783
[patent_doc_number] => 06051429
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-04-18
[patent_title] => 'Peptide-enhanced cationic lipid transfections'
[patent_app_type] => 1
[patent_app_number] => 8/818200
[patent_app_country] => US
[patent_app_date] => 1997-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 40860
[patent_no_of_claims] => 95
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/051/06051429.pdf
[firstpage_image] =>[orig_patent_app_number] => 818200
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/818200 | Peptide-enhanced cationic lipid transfections | Mar 13, 1997 | Issued |
Array
(
[id] => 4084022
[patent_doc_number] => 06025193
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-02-15
[patent_title] => 'Methods and compositions for diagnosis and treatment of pathological conditions related to abnormal dopamine receptor expression'
[patent_app_type] => 1
[patent_app_number] => 8/816426
[patent_app_country] => US
[patent_app_date] => 1997-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 30
[patent_no_of_words] => 18603
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/025/06025193.pdf
[firstpage_image] =>[orig_patent_app_number] => 816426
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/816426 | Methods and compositions for diagnosis and treatment of pathological conditions related to abnormal dopamine receptor expression | Mar 13, 1997 | Issued |
Array
(
[id] => 3943275
[patent_doc_number] => 05998204
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-12-07
[patent_title] => 'Fluorescent protein sensors for detection of analytes'
[patent_app_type] => 1
[patent_app_number] => 8/818253
[patent_app_country] => US
[patent_app_date] => 1997-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 17
[patent_no_of_words] => 27015
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/998/05998204.pdf
[firstpage_image] =>[orig_patent_app_number] => 818253
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/818253 | Fluorescent protein sensors for detection of analytes | Mar 13, 1997 | Issued |
Array
(
[id] => 3803219
[patent_doc_number] => 05830698
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-03
[patent_title] => 'Method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same'
[patent_app_type] => 1
[patent_app_number] => 8/819866
[patent_app_country] => US
[patent_app_date] => 1997-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 54
[patent_figures_cnt] => 54
[patent_no_of_words] => 9821
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 226
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/830/05830698.pdf
[firstpage_image] =>[orig_patent_app_number] => 819866
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/819866 | Method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same | Mar 13, 1997 | Issued |
Array
(
[id] => 4001712
[patent_doc_number] => 06004777
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-12-21
[patent_title] => 'Vectors having enhanced expression, and methods of making and uses thereof'
[patent_app_type] => 1
[patent_app_number] => 8/815809
[patent_app_country] => US
[patent_app_date] => 1997-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 22444
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/004/06004777.pdf
[firstpage_image] =>[orig_patent_app_number] => 815809
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/815809 | Vectors having enhanced expression, and methods of making and uses thereof | Mar 11, 1997 | Issued |
| 08/814365 | TRICARBOXYLIC ACID-CONTAINING OXYALKYL ESTERS AND USES THEREOF | Mar 10, 1997 | Abandoned |
Array
(
[id] => 3804716
[patent_doc_number] => 05854010
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-29
[patent_title] => 'Bioassay for detecting 2,3,7,8-tetrachlorodibenzo-para-dioxin and TCDD-like compounds and novel recombinant cell line useful therefor'
[patent_app_type] => 1
[patent_app_number] => 8/813321
[patent_app_country] => US
[patent_app_date] => 1997-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7979
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/854/05854010.pdf
[firstpage_image] =>[orig_patent_app_number] => 813321
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/813321 | Bioassay for detecting 2,3,7,8-tetrachlorodibenzo-para-dioxin and TCDD-like compounds and novel recombinant cell line useful therefor | Mar 9, 1997 | Issued |
Array
(
[id] => 307287
[patent_doc_number] => 07531353
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2009-05-12
[patent_title] => 'Non self-inactivating, expression targeted retroviral vectors'
[patent_app_type] => utility
[patent_app_number] => 08/808827
[patent_app_country] => US
[patent_app_date] => 1997-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 17
[patent_no_of_words] => 7145
[patent_no_of_claims] => 65
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/531/07531353.pdf
[firstpage_image] =>[orig_patent_app_number] => 08808827
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/808827 | Non self-inactivating, expression targeted retroviral vectors | Feb 27, 1997 | Issued |
Array
(
[id] => 4190204
[patent_doc_number] => 06130062
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-10-10
[patent_title] => 'Production of proteins in host cells'
[patent_app_type] => 1
[patent_app_number] => 8/793418
[patent_app_country] => US
[patent_app_date] => 1997-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 18
[patent_no_of_words] => 11530
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/130/06130062.pdf
[firstpage_image] =>[orig_patent_app_number] => 793418
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/793418 | Production of proteins in host cells | Feb 24, 1997 | Issued |
Array
(
[id] => 3809080
[patent_doc_number] => 05811407
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-09-22
[patent_title] => 'System for the in vivo delivery and expression of heterologous genes in the bone marrow'
[patent_app_type] => 1
[patent_app_number] => 8/801263
[patent_app_country] => US
[patent_app_date] => 1997-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17813
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/811/05811407.pdf
[firstpage_image] =>[orig_patent_app_number] => 801263
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/801263 | System for the in vivo delivery and expression of heterologous genes in the bone marrow | Feb 18, 1997 | Issued |
Array
(
[id] => 4018341
[patent_doc_number] => 05906925
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-05-25
[patent_title] => 'Microorganisms and methods for overproduction of DAHP by cloned pps gene'
[patent_app_type] => 1
[patent_app_number] => 8/801454
[patent_app_country] => US
[patent_app_date] => 1997-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 14
[patent_no_of_words] => 11339
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/906/05906925.pdf
[firstpage_image] =>[orig_patent_app_number] => 801454
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/801454 | Microorganisms and methods for overproduction of DAHP by cloned pps gene | Feb 17, 1997 | Issued |
Array
(
[id] => 1446325
[patent_doc_number] => 06368790
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-04-09
[patent_title] => 'cDNA encoding P2P proteins and use of P2P cDNA derived antibodies and antisense reagents in determining the proliferative potential of normal, abnormal, and cancer cells in animals and humans'
[patent_app_type] => B1
[patent_app_number] => 08/801308
[patent_app_country] => US
[patent_app_date] => 1997-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 8707
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/368/06368790.pdf
[firstpage_image] =>[orig_patent_app_number] => 08801308
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/801308 | cDNA encoding P2P proteins and use of P2P cDNA derived antibodies and antisense reagents in determining the proliferative potential of normal, abnormal, and cancer cells in animals and humans | Feb 17, 1997 | Issued |
| 08/798692 | MEMBER OF THE TNF FAMILY USEFUL FOR TREATMENT AND DIAGNOSIS OF DISEASE | Feb 11, 1997 | Abandoned |
Array
(
[id] => 3737935
[patent_doc_number] => 05753462
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-05-19
[patent_title] => 'Secretion leader trap cloning method'
[patent_app_type] => 1
[patent_app_number] => 8/796508
[patent_app_country] => US
[patent_app_date] => 1997-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7670
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/753/05753462.pdf
[firstpage_image] =>[orig_patent_app_number] => 796508
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/796508 | Secretion leader trap cloning method | Feb 5, 1997 | Issued |
Array
(
[id] => 3739421
[patent_doc_number] => 05786174
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-07-28
[patent_title] => 'Thermophile gene transfer'
[patent_app_type] => 1
[patent_app_number] => 8/790309
[patent_app_country] => US
[patent_app_date] => 1997-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 12581
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/786/05786174.pdf
[firstpage_image] =>[orig_patent_app_number] => 790309
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/790309 | Thermophile gene transfer | Jan 27, 1997 | Issued |
Array
(
[id] => 1449547
[patent_doc_number] => 06455247
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-09-24
[patent_title] => 'Methods for screening for transdominant effector peptides and RNA molecules'
[patent_app_type] => B1
[patent_app_number] => 08/787738
[patent_app_country] => US
[patent_app_date] => 1997-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 33750
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/455/06455247.pdf
[firstpage_image] =>[orig_patent_app_number] => 08787738
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/787738 | Methods for screening for transdominant effector peptides and RNA molecules | Jan 22, 1997 | Issued |